Fiduciary Trust Co. Boosts Stake in Danaher Co. (DHR)

Fiduciary Trust Co. grew its position in Danaher Co. (NYSE:DHR) by 12.5% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 24,797 shares of the conglomerate’s stock after purchasing an additional 2,765 shares during the quarter. Fiduciary Trust Co.’s holdings in Danaher were worth $3,274,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of DHR. Canton Hathaway LLC grew its position in Danaher by 8.7% during the first quarter. Canton Hathaway LLC now owns 12,886 shares of the conglomerate’s stock worth $1,701,000 after buying an additional 1,036 shares in the last quarter. Abacus Planning Group Inc. grew its position in Danaher by 52.3% during the fourth quarter. Abacus Planning Group Inc. now owns 9,979 shares of the conglomerate’s stock worth $225,000 after buying an additional 3,428 shares in the last quarter. Municipal Employees Retirement System of Michigan acquired a new stake in Danaher during the fourth quarter worth approximately $1,705,000. IHT Wealth Management LLC grew its position in Danaher by 5.1% during the fourth quarter. IHT Wealth Management LLC now owns 2,023 shares of the conglomerate’s stock worth $209,000 after buying an additional 98 shares in the last quarter. Finally, Findlay Park Partners LLP grew its position in Danaher by 0.9% during the first quarter. Findlay Park Partners LLP now owns 4,635,000 shares of the conglomerate’s stock worth $611,913,000 after buying an additional 40,000 shares in the last quarter. 79.98% of the stock is currently owned by institutional investors.

In other news, EVP William K. Daniel sold 7,534 shares of the stock in a transaction on Tuesday, May 21st. The stock was sold at an average price of $131.27, for a total value of $988,988.18. Following the completion of the transaction, the executive vice president now directly owns 115,778 shares in the company, valued at approximately $15,198,178.06. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Daniel L. Comas sold 97,357 shares of the stock in a transaction on Wednesday, February 27th. The shares were sold at an average price of $127.04, for a total value of $12,368,233.28. Following the completion of the transaction, the executive vice president now owns 134,039 shares of the company’s stock, valued at $17,028,314.56. The disclosure for this sale can be found here. Insiders sold a total of 444,484 shares of company stock valued at $57,676,574 over the last quarter. 11.40% of the stock is owned by corporate insiders.



DHR has been the topic of a number of research analyst reports. Janney Montgomery Scott raised Danaher from a “neutral” rating to a “buy” rating in a report on Monday, February 25th. JPMorgan Chase & Co. reaffirmed an “overweight” rating and issued a $140.00 target price on shares of Danaher in a report on Monday, March 4th. UBS Group raised their target price on Danaher from $125.00 to $144.00 and gave the company a “buy” rating in a report on Tuesday, February 26th. Deutsche Bank raised their target price on Danaher to $130.00 and gave the company a “buy” rating in a report on Tuesday, February 26th. Finally, Jefferies Financial Group raised their target price on Danaher to $140.00 and gave the company a “buy” rating in a report on Tuesday, February 26th. Two equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $131.75.

Shares of DHR stock opened at $132.04 on Friday. The firm has a market capitalization of $94.53 billion, a price-to-earnings ratio of 29.21, a price-to-earnings-growth ratio of 2.52 and a beta of 1.02. Danaher Co. has a fifty-two week low of $94.59 and a fifty-two week high of $134.67. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.74 and a current ratio of 2.18.

Danaher (NYSE:DHR) last issued its earnings results on Thursday, April 18th. The conglomerate reported $1.07 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.01 by $0.06. The firm had revenue of $4.88 billion for the quarter, compared to the consensus estimate of $4.80 billion. Danaher had a return on equity of 11.61% and a net margin of 12.04%. The company’s revenue was up 3.9% compared to the same quarter last year. During the same quarter last year, the business posted $0.99 EPS. On average, analysts forecast that Danaher Co. will post 4.77 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.51%. The ex-dividend date of this dividend is Thursday, June 27th. Danaher’s payout ratio is 15.04%.

COPYRIGHT VIOLATION WARNING: This piece was originally posted by Dakota Financial News and is the sole property of of Dakota Financial News. If you are reading this piece on another website, it was illegally copied and reposted in violation of US & international copyright laws. The legal version of this piece can be read at https://dakotafinancialnews.com/2019/05/26/fiduciary-trust-co-boosts-stake-in-danaher-co-dhr.html.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Featured Article: What is the Consumer Price Index (CPI)?

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.